Search Results for keywords:"Infectious Diseases"

The Centers for Disease Control and Prevention (CDC), part of the Department of Health and Human Services, is awarding around $20 million to the World Health Organization (WHO), with the total expected funding to reach approximately $100 million over five years. This funding will help CDC and WHO work together to improve the world's ability to detect, respond to, and prevent infectious diseases. The focus is on building infrastructure and preparing for disease outbreaks, using WHO's global network to support these efforts. The award period is from September 2025 to September 2030.

The National Institutes of Health (NIH) announced a closed meeting for the National Institute of Allergy and Infectious Diseases Special Emphasis Panel. This meeting, set for January 7, 2025, will focus on reviewing and evaluating contract proposals related to using artificial intelligence to enhance clinical microscopy for diagnosing infectious diseases. Due to confidential matters concerning trade secrets and personal privacy, the meeting will not be open to the public, and it will take place virtually at the NIH's Rockville, MD location.

The National Institute of Allergy and Infectious Diseases announced a closed meeting of the Microbiology, Infectious Diseases, and AIDS Research Study Section scheduled for April 23-24, 2025. The meeting will take place from 11:00 a.m. to 6:00 p.m. and will be conducted via video. The purpose of this meeting is to review and evaluate grant applications, with discussions potentially including confidential information. This information will be kept private to protect trade secrets and personal privacy.

The Centers for Disease Control and Prevention (CDC) has announced changes to the meeting notice for the Disease, Disability, and Injury Prevention and Control Special Emphasis Panel. This involves three specific research funding announcements focusing on US Travelers Health, Emerging Infections Networks, and monitoring school absenteeism related to influenza and SARS-CoV-2. Gregory Anderson is the contact person for more information. Kalwant Smagh, as the Director of the Strategic Business Initiatives Unit at the CDC, has the authority to sign Federal Register notices about these meetings and committee activities.

The National Institute of Allergy and Infectious Diseases has announced a closed meeting for the Microbiology, Infectious Diseases and AIDS Initial Review Group. This meeting, scheduled for April 15-17, 2025, will be conducted via video and will focus on reviewing and evaluating grant applications. The meeting is closed to the public due to potential disclosure of confidential information and personal privacy concerns. The contact person for any queries is Dr. Noton Kumar Dutta.

The Center for Scientific Review at the National Institutes of Health has announced several upcoming closed meetings. These meetings, held virtually, are scheduled for April 22-23 and April 30-May 1, 2025, and will focus on reviewing and evaluating grant applications related to infectious diseases and immunology. The meetings will remain closed to protect sensitive information, including trade secrets and personal details associated with the grant applications. The Federal Advisory Committee Act guidelines are followed to ensure confidentiality.